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Meropenem is a carbapenem that has an excellent activity against many gram-
positive and gram-negative aerobic, facultative, and anaerobic bacteria. The major
objective of the present study was to assess the in vitro activity of meropenem
compared to imipenem and piperacillin/tazobactam, against 1071 non-repetitive
isolates collected from patients with bacteremia (55%), pneumonia (29%),
peritonitis (12%) and wound infections (3%), in 15 French hospitals in 2006. The
secondary aim of the study was to compare the results of routinely testings and
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